Overall CONE gets a fundamental rating of 1 out of 10. We evaluated CONE against 126 industry peers in the Diversified REITs industry. Both the profitability and financial health of CONE have multiple concerns. CONE is quite expensive at the moment. It does show a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.34% | ||
| ROE | 0.87% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.86% | ||
| PM (TTM) | 2.1% | ||
| GM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.25 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 244.22 | ||
| Fwd PE | 508.02 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 27.17 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.3% |
90.36
+0.03 (+0.03%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.3% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 244.22 | ||
| Fwd PE | 508.02 | ||
| P/S | 9.83 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 4.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | 27.17 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.34% | ||
| ROE | 0.87% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 4.86% | ||
| PM (TTM) | 2.1% | ||
| GM | N/A | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.25 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
ChartMill assigns a fundamental rating of 1 / 10 to CONE.
ChartMill assigns a valuation rating of 0 / 10 to CYRUSONE INC (CONE). This can be considered as Overvalued.
CYRUSONE INC (CONE) has a profitability rating of 1 / 10.
The financial health rating of CYRUSONE INC (CONE) is 1 / 10.
The Earnings per Share (EPS) of CYRUSONE INC (CONE) is expected to decline by -51.93% in the next year.